Annual Current Liabilities
$2.09 M
-$5.54 M-72.65%
31 December 2023
Summary:
Cyclerion Therapeutics annual total current liabilities is currently $2.09 million, with the most recent change of -$5.54 million (-72.65%) on 31 December 2023. During the last 3 years, it has fallen by -$14.87 million (-87.69%). CYCN annual current liabilities is now -88.57% below its all-time high of $18.25 million, reached on 31 December 2019.CYCN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$700.00 K
-$582.00 K-45.40%
30 September 2024
Summary:
Cyclerion Therapeutics quarterly total current liabilities is currently $700.00 thousand, with the most recent change of -$582.00 thousand (-45.40%) on 30 September 2024. Over the past year, it has dropped by -$1.64 million (-70.10%). CYCN quarterly current liabilities is now -96.81% below its all-time high of $21.92 million, reached on 30 June 2019.CYCN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCN Current Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -72.7% | -70.1% |
3 y3 years | -87.7% | -93.8% |
5 y5 years | -88.3% | -96.3% |
CYCN Current Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -87.7% | at low | -93.8% | at low |
5 y | 5 years | -88.6% | at low | -96.3% | at low |
alltime | all time | -88.6% | at low | -96.8% | at low |
Cyclerion Therapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $700.00 K(-45.4%) |
June 2024 | - | $1.28 M(-11.0%) |
Mar 2024 | - | $1.44 M(-30.9%) |
Dec 2023 | $2.09 M(-72.6%) | $2.09 M(-10.9%) |
Sept 2023 | - | $2.34 M(-52.7%) |
June 2023 | - | $4.95 M(-34.3%) |
Mar 2023 | - | $7.53 M(-1.3%) |
Dec 2022 | $7.63 M(-31.2%) | $7.63 M(-10.6%) |
Sept 2022 | - | $8.53 M(-13.4%) |
June 2022 | - | $9.85 M(+3.8%) |
Mar 2022 | - | $9.49 M(-14.4%) |
Dec 2021 | $11.09 M | $11.09 M(-2.4%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $11.36 M(+8.0%) |
June 2021 | - | $10.51 M(-22.0%) |
Mar 2021 | - | $13.47 M(-20.6%) |
Dec 2020 | $16.95 M(-7.1%) | $16.95 M(+4.2%) |
Sept 2020 | - | $16.26 M(+3.9%) |
June 2020 | - | $15.64 M(+36.8%) |
Mar 2020 | - | $11.44 M(-37.3%) |
Dec 2019 | $18.25 M(+2.3%) | $18.25 M(-4.4%) |
Sept 2019 | - | $19.10 M(-12.9%) |
June 2019 | - | $21.92 M(+25.4%) |
Mar 2019 | - | $17.47 M(-2.1%) |
Dec 2018 | $17.85 M(+27.1%) | $17.85 M |
Dec 2017 | $14.04 M | - |
FAQ
- What is Cyclerion Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual current liabilities year-on-year change?
- What is Cyclerion Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics quarterly current liabilities year-on-year change?
What is Cyclerion Therapeutics annual total current liabilities?
The current annual current liabilities of CYCN is $2.09 M
What is the all time high annual current liabilities for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual total current liabilities is $18.25 M
What is Cyclerion Therapeutics annual current liabilities year-on-year change?
Over the past year, CYCN annual total current liabilities has changed by -$5.54 M (-72.65%)
What is Cyclerion Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of CYCN is $700.00 K
What is the all time high quarterly current liabilities for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly total current liabilities is $21.92 M
What is Cyclerion Therapeutics quarterly current liabilities year-on-year change?
Over the past year, CYCN quarterly total current liabilities has changed by -$1.64 M (-70.10%)